(Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | (Q6)Jun 30, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -21.40%7.36B | -1.10%18.95B | 0.10%9.36B | 19.21%19.16B | 38.98%9.35B | 18.02%16.07B | 52.49%6.73B | 79.00%13.62B | 51.79%4.41B | 105.47%7.61B |
Operating income | -21.40%7.36B | -1.10%18.95B | 0.10%9.36B | 19.21%19.16B | 38.98%9.35B | 18.02%16.07B | 52.49%6.73B | 79.00%13.62B | 51.79%4.41B | 105.47%7.61B |
Cost of sales | 10.15%-5.72B | -4.88%-13.55B | -8.72%-6.37B | -19.29%-12.92B | -39.35%-5.86B | -18.83%-10.83B | -41.78%-4.2B | -81.09%-9.11B | -56.49%-2.97B | -106.38%-5.03B |
Operating expenses | 10.15%-5.72B | -4.88%-13.55B | -8.72%-6.37B | -19.29%-12.92B | -39.35%-5.86B | -18.83%-10.83B | -41.78%-4.2B | -81.09%-9.11B | -56.49%-2.97B | -106.38%-5.03B |
Gross profit | -45.34%1.64B | -13.48%5.4B | -14.34%2.99B | 19.05%6.24B | 38.38%3.5B | 16.39%5.24B | 74.43%2.53B | 74.92%4.5B | 43.00%1.45B | 103.71%2.57B |
Selling expenses | 53.84%-66.9M | 6.56%-288.83M | 7.29%-144.93M | -1.88%-309.1M | -44.40%-156.34M | 15.48%-303.41M | -5.46%-108.26M | -115.54%-358.98M | -75.63%-102.65M | -27.92%-166.55M |
Administrative expenses | -0.06%-163.89M | -1.35%-491.27M | 19.47%-163.79M | 1.54%-484.71M | -15.79%-203.39M | -17.21%-492.3M | -43.71%-175.65M | -95.05%-420.01M | -145.99%-122.22M | -139.64%-215.33M |
Revaluation surplus | -229.23%-117.6M | -53.49%-272.45M | 71.79%-35.72M | -140.60%-177.5M | -174.13%-126.61M | 15.42%437.24M | -65.15%170.8M | 75.89%378.82M | 268.55%490.05M | -36.25%215.37M |
-Changes in the fair value of investment property | -229.23%-117.6M | -53.49%-272.45M | 71.79%-35.72M | -140.60%-177.5M | -174.13%-126.61M | 19.50%437.24M | -63.66%170.8M | 69.89%365.89M | 253.47%470M | -36.25%215.37M |
-Changes in the fair value of financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --12.93M | --20.05M | ---- |
Impairment and provision | 342.65%18.14M | -58.23%-98.29M | 133.38%4.1M | -411.51%-62.12M | -136.25%-12.28M | 121.04%19.94M | --33.86M | ---94.76M | ---- | ---- |
-Other impairment is provision | 342.65%18.14M | -58.23%-98.29M | 133.38%4.1M | -411.51%-62.12M | -136.25%-12.28M | 121.04%19.94M | --33.86M | ---94.76M | ---- | ---- |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -55.64%-67.27M | -173.16%-177.29M |
Special items of operating profit | -149.07%-225.01M | -51.66%599.95M | 2,844.56%458.56M | 1,331.37%1.24B | -86.65%15.57M | -49.09%86.7M | 202.46%116.63M | 26.33%170.31M | -478.71%-113.84M | -11.92%134.81M |
Operating profit | -65.26%1.08B | -24.81%4.85B | 3.32%3.11B | 29.21%6.45B | 17.52%3.01B | 19.40%4.99B | 67.30%2.56B | 76.65%4.18B | 49.58%1.53B | 60.95%2.37B |
Financing cost | 99.05%-277K | 32.11%-216.27M | 81.02%-29.28M | -12.68%-318.55M | -102.48%-154.3M | 3.65%-282.7M | ---76.2M | ---293.4M | ---- | ---- |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 105,900.00%1.06M | --598K |
Special items of earning before tax | -161.79%-15.61M | -139.01%-48.78M | -81.37%25.27M | 52.38%125.04M | 665.94%135.63M | -86.49%82.06M | ---23.97M | --607.37M | ---- | ---- |
Earning before tax | -65.73%1.07B | -26.73%4.58B | 3.83%3.11B | 30.59%6.25B | 21.54%2.99B | 6.60%4.79B | 60.65%2.46B | 89.88%4.49B | 49.68%1.53B | 60.99%2.37B |
Tax | 43.60%-529.13M | 27.57%-1.91B | 24.85%-938.12M | -13.17%-2.64B | -19.40%-1.25B | -8.78%-2.33B | -108.90%-1.05B | -109.44%-2.14B | 0.37%-500.43M | -54.74%-1.02B |
After-tax profit from continuing operations | -75.30%536.08M | -26.11%2.67B | 24.33%2.17B | 47.07%3.62B | 23.12%1.75B | 4.60%2.46B | 37.27%1.42B | 75.00%2.35B | 97.83%1.03B | 66.10%1.34B |
Earning after tax | -75.30%536.08M | -26.11%2.67B | 24.33%2.17B | 47.07%3.62B | 23.12%1.75B | 4.60%2.46B | 37.27%1.42B | 75.00%2.35B | 97.83%1.03B | 66.10%1.34B |
Minority profit | 10.37%209.91M | 5.49%254.13M | 50.58%190.18M | -41.22%240.91M | 274.22%126.3M | 249.19%409.82M | 218.32%33.75M | 910.44%117.36M | 51.30%10.6M | 695.95%11.62M |
Profit attributable to shareholders | -83.52%326.18M | -28.36%2.42B | 22.28%1.98B | 64.72%3.38B | 16.99%1.62B | -8.24%2.05B | 35.39%1.38B | 67.72%2.23B | 98.46%1.02B | 64.27%1.33B |
Basic earnings per share | -84.85%0.05 | -29.31%0.41 | 17.86%0.33 | 11.47%0.58 | -20.30%0.28 | -8.90%0.5203 | -13.32%0.3513 | -10.90%0.5711 | 50.61%0.4053 | 39.77%0.641 |
Diluted earnings per share | -87.88%0.04 | -29.31%0.41 | 17.86%0.33 | 11.47%0.58 | -20.30%0.28 | -8.90%0.5203 | 0.3513 | 0.5711 | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data